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Abstract
The human pathogen Streptococcus pneumoniae is a strictly fermentative organism that
relies on glycolytic metabolism to obtain energy. In the human nasopharynx S. pneumoniae
encounters glycoconjugates composed of a variety of monosaccharides, which can poten-
tially be used as nutrients once depolymerized by glycosidases. Therefore, it is reasonable
to hypothesise that the pneumococcus would rely on these glycan-derived sugars to grow.
Here, we identified the sugar-specific catabolic pathways used by S. pneumoniae during
growth on mucin. Transcriptome analysis of cells grown on mucin showed specific upregu-
lation of genes likely to be involved in deglycosylation, transport and catabolism of galac-
tose, mannose and N acetylglucosamine. In contrast to growth on mannose and N-
acetylglucosamine, S. pneumoniae grown on galactose re-route their metabolic pathway
from homolactic fermentation to a truly mixed acid fermentation regime. By measuring intra-
cellular metabolites, enzymatic activities and mutant analysis, we provide an accurate map
of the biochemical pathways for galactose, mannose and N-acetylglucosamine catabolism
in S. pneumoniae. Intranasal mouse infection models of pneumococcal colonisation and
disease showed that only mutants in galactose catabolic genes were attenuated. Our data
pinpoint galactose as a key nutrient for growth in the respiratory tract and highlights the im-
portance of central carbon metabolism for pneumococcal pathogenesis.
Introduction
Streptococcus pneumoniae is an important human pathogen responsible for high morbidity
and mortality worldwide, mainly due to community-acquired pneumonia, meningitis, bacter-
aemia and otitis media [1,2]. The pneumococcus is, however, also a transient commensal that
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asymptomatically resides and proliferates in the human nasopharynx [3]. Colonisation of the
nasopharynx is of importance as it represents a reservoir from which bacteria can disseminate
throughout the community [2,4]. Furthermore, the establishment of a carrier state is accepted
to be a pre-requisite for disease [3,5]. Despite the significance of colonisation to the lifestyle of
S. pneumoniae, little is known about the mechanisms employed by the bacterium to grow and
proliferate in the human nasopharynx.
S. pneumoniae is a strictly fermentative bacterium that relies on glycolytic metabolism to
obtain energy [6]. Therefore, the ability to acquire and metabolize sugars is of major impor-
tance for in vivo fitness of this microorganism. Indeed, the pneumococcus lacks a complete set
of genes for respiratory proteins and is for this reason unable to generate energy by respiration
[6,7]. The genomic abundance of genes involved in sugar transport further supports the signifi-
cant role of carbohydrates in the lifestyle of S. pneumoniae [6,7]. Over 30% of the transporters
in the S. pneumoniae genome were predicted to be involved in the uptake of carbohydrates [7],
and these predictions were validated by a recent functional genomic approach targeting carbo-
hydrate transport [8]. Furthermore, several putative carbohydrate degradation pathways have
been annotated in the genome sequences of S. pneumoniae [6,7]. In summary, S. pneumoniae
potentially harbours an incredible flexibility with respect to sugar consumption. Hexoses, and
in particular glucose (Glc), are the preferred carbon and energy sources of S. pneumoniae [9].
However, in the human airway the abundance of free sugars is scarce, the concentration of
Glc being below 1 mM [10,11]. In this case, in vivo growth must rely on alternative nutritional
reservoirs. In the human nasopharynx, the glycoproteins lining the epithelial surfaces appear
as good candidates to serve as carbon and energy sources for pneumococcal growth. Impor-
tantly, S. pneumoniae is able to grow on mucin as a sole carbon source [12]. Mucins are major
components of the mucus that cover the epithelial surfaces [13]. These structures are heavily
O-glycosylated glycoproteins and despite their composition variability, mucins are generally
composed of N-acetylglucosamine (GlcNAc), N-acetylgalactosamine (GalNAc), N-acetylneur-
aminic acid (NeuNAc), galactose (Gal), fucose (Fuc) and sulphated sugars linked to the protein
core, most commonly via a N-acetylgalactosamine moiety [13,14]. Furthermore, S. pneumo-
niae can use other host glycans, such as N-glycans and glycosaminoglycans [15,16]. In fact, the
pneumococcus is equipped with a high number of extracellular glycosidases covering a wide
range of substrates specificities (reviewed in [17]). The action of these enzymes on host glycans
generates a variety of free sugars that potentially can be used by the pneumococcus. The degly-
cosylation activity of both exo- and endoglycosidades has been previously demonstrated in S.
pneumoniae [15,18–20]. Furthermore, the role of these enzymes in in vivo fitness is substantiat-
ed by the observations that glycosidase mutants show attenuated ability to colonise and to
cause disease in mouse models [14,19–23].
In this study, we set out to identify the putative catabolic pathways important for growth on
mucin. To this end, we used the well-established laboratorial model for pneumococcal studies S.
pneumoniaeD39 [24]. Subsequently, the predicted utilization routes of the glycan-derived sug-
ars Gal, GlcNAc andMan were functionally established, by positive detection of phosphorylated
metabolic intermediates and measurement of specific enzyme activities. Inactivation of a unique
gene in each catabolic pathway rendered mutant strains unable or with impaired ability to grow
in the presence of the corresponding sugar. Finally, the contribution of the sugar-specific cata-
bolic pathways to colonisation and pneumococcal disease was assessed in appropriate mouse
models, demonstrating that mutants in Gal catabolic pathways were attenuated in their ability
to colonise and had reduced virulence in respiratory infection models.
Overall, we experimentally validated the catabolic pathways of glycan-derived Gal, Man and
GlcNAc and found Gal as a key nutrient during pneumococcal in vivo growth.
Pathways for Glycan-Derived Sugars in S. pneumonia
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Materials and Methods
Bacterial strains and growth conditions
Streptococcus pneumoniae strain D39 (serotype 2) and its derivatives are listed in S1 Table. The
D39 isolate was obtained from the culture collection of the Department of Infection, Immunity
and Inflammation, of the University of Leicester. Stocks and working stocks were prepared as
described elsewhere [25] and stored in 25% (vol/vol) glycerol M17 medium (Difco) at -80°C.
Routinely, S. pneumoniae was grown statically in M17 broth containing 0.5% (wt/vol) glu-
cose (Glc-M17) at 37°C. For physiological studies, bacteria were grown in static rubber-stop-
pered bottles (80 ml in 100 ml bottles) at 37ºC and without pH control (initial pH 6.5) in the
chemically defined medium (CDM) described by Carvalho et al. [25]. For each sugar tested
(Gal, GlcNAc, Man and Glc), growth was analysed under sugar excess (34±2 mM) and a lower
concentration (13±1 mM). In sugar mixtures each carbohydrate (Gal, Man and GlcNAc) was
added to an initial concentration of circa 6.5 mM. Cultures were started by inoculating fresh
CDM, to an initial optical density at 600 nm (OD600) of ~0.05, with a pre-culture grown until
late-exponential phase of growth. Pre-cultures were performed as described previously [25].
Pre-cultures for growth on sugar mixtures were grown in CDM containing 30 mM of each car-
bon source. Growth was monitored by measuring OD600 hourly. Maximum specific growth
rates (μmax) were calculated through linear regressions of the plots of ln(OD600) versus time
during the exponential phase of growth. The values reported are averages of at least eight
independent growths.




þ mmax  mmax
SDmmax
 !2
Where, ODmax and mmax are the averages of the maximum optical density (ODmax) and μmax, re-
spectively; SDODmax and SDμmax are the standard deviation of ODmax and μmax, respectively.
Statistical analysis of the growth parameters
ANOVA was applied to test the hypothesis that μmax values are independent of the sugar. Ad-
ditionally, the differences across the two initial substrate conditions were also compared. The
same ANOVA procedure was taken to assess if differences of ODmax values depended on the
sugar and initial condition and assess if they were statistically significant.
The null hypothesis of equal values for the μmax was tested for all possible pairwise combina-
tions of initial conditions and sugars. This was accomplished by independent two-sample t-
tests, whose results are summarized on S2 Table. Likewise, similar tests were also performed
for the ODmax. Results are presented in S2 Table.
Multiple non-linear regression method for generating confidence interval
bands
Multiple non-linear regressions were performed for all the combinations of experimental con-
ditions (4 sugars and 2 initial concentrations) using the Gompertz model [26]:
f ðt; mmax; l;AÞ ¼ A  exp exp
mmax  expð1Þ
A
ðl tÞ þ 1
  
;
where μmax is the tangent in the inﬂection point (maximum growth rate), λ is the x-axis inter-
cept of this tangent (lag) and A is the asymptote A ¼ log y1
y0
 
. To obtain better ﬁttings, the
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data were previously log-transformed as y0 ¼ log y
y0
 
and the parameters estimated directly
with the BGFit web-application [27] using non-linear least squares.
After obtaining the estimates for each sugar and initial concentration condition, a 95% con-
fidence interval for the data and bands for the predicted responses of the model were comput-
ed. These computations were performed in MATLAB and Statistics Toolbox R2013a using the
function nlpredci.
General molecular techniques
Chromosomal DNA isolation was performed according to the procedure described by Johan-
sen and Kibenich [28]. Pwo polymerase was used according to the supplier’s instructions
(Roche). PCRs were performed with a MyCycler thermal cycler (Bio-Rad). Purification of the
PCR fragments was accomplished using the High Pure PCR product Purification Kit (Roche)
according to the supplier’s instructions. Plasmid isolation was done using a High Pure Plasmid
Isolation Kit (Roche), according to the manufacturer’s protocol. Restriction enzymes were pur-
chased from New England Biolabs.
Construction of loss-of-function mutants
Chromosomal DNA of S. pneumoniae D39 was used as template in the PCR amplifications.
Oligonucleotide primers used for these constructs are listed in S3 Table. galK (SPD_1634),
lacD (SPD_1050),manA (SPD_0641), nagA (SPD_1866) and galT-2 (SPD_1633) disruption
was accomplished by allelic replacement mutagenesis, essentially as described by Song et al.
[29]. The upstream and downstream flanking regions of the genes to be disrupted were ampli-
fied using the appropriate primers’ combinations KO1_Fw/KO2_Rv_Spe and KO3_Fw_Spe/
KO4_Rv, respectively (S3 Table). Flanking fragments were fused to the spectinomycin resis-
tance marker (Spe) (1032 bp, amplified with primers Spe_Fp and Spe_Rp from pORI38), by
overlap extension PCR using the appropriate primers KO1_Fw and KO4_Rv. The resulting
fused fragments were purified and transformed into D39 as described before [30]. Positive
transformants were selected on Glc-M17 sheep blood (1% vol/vol) agar plates supplemented
with 150 μg ml-1 of spectinomycin. The correct integration of the insert in the mutant clones
was confirmed by PCR. Genomic DNA was used as template for PCR with primers designed to
anneal around 100 bp upstream and downstream of the recombination site, as well as combina-
tions of these primers with those used to construct the mutants (S3 Table).
A double mutant, D39ΔlacDΔgalK, was constructed by allelic replacement of the galK
gene in the D39ΔlacDmutant using trimethoprim (Tmp) selection. The up and downstream
flanking regions of the galK gene were amplified using the appropriate primer combinations:
GalK_KO1_Fw/GalK_KO2_Rv_Tmp and GalK_KO3_Fw_Tmp/GalK_KO4_Rv, respectively
(S3 Table). The regions flanking galK were fused to the Tmp cassette in an overlap extension
PCR reaction with the primer combination GalK_KO1_Fw/GalK_KO4_Rv, yielding ΔgalK::
tmp. The purified fused fragment was transformed into D39ΔlacD and positive clones were se-
lected on Glc-M17 sheep blood (1% vol/vol) agar plates supplemented with 18 μg ml-1 of tri-
methoprim. Gene replacement was confirmed as described above, using the primers listed in
S3 Table.
Construction of the pKB01 derivatives for complementation studies
pKB01, containing a zinc-inducible PczcD promoter (PZn), was used as a complementation system
[31]. The target genes were amplified using chromosomal DNA from S. pneumoniaeD39. For
the construction of pKB01-lacD, pKB01-galK and pKB01-manA, lacD, galK andmanA genes
Pathways for Glycan-Derived Sugars in S. pneumonia
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were amplified using LacD_Fw_EcoRI/LacD_Rv_BamHI, GalK_Fw_EcoRI/GalK_Rv_BamHI
andManA_Fw_EcoRI/ManA_Rv_BamHI, respectively. The PCR-amplified fragments and
pKB01 were digested with EcoRI and BamHI and subsequently ligated. To generate pKB01-
nagA the gene was amplified with its own promoter using primers NagA_Fw_NotI/NagA_Rv_
BamHI. The digested fragment (NotI/BamHI) was cloned into pKB01 using the same restriction
sites. pKB01-galT-2was made by amplifying galT-2with GalT-2_Fw_EcoRI/GalT-2_Rv_NotI.
The PCR-fragment and PKB01 were cleaved using EcoRI/NotI enzymes and ligated. To con-
struct PKB01-galKgalT-2, galKgalT-2was amplified using GalK_Fw_EcoRI_B/GalT-2_Rv_XbaI,
digested with EcoRI and XbaI and ligated into pKB01 at the same restriction sites. The primers
used are listed in S3 Table.
All the generated constructs were transformed into E. coliDH5α [32]. E. coli was grown in
Luria broth at 37ºC supplemented with 100 μg ml-1 ampicillin. The constructs were verified by
sequencing at Macrogen.
Complementation of deletion strains
The pKB01-based plasmids were transformed into competent cells of S. pneumoniae D39 loss-
of-function mutants. For transformation, 2 μl of the competence-stimulating peptide (CSP,
0.1 mg ml-1) was added to pre-competent cells and activation achieved by 12 min at 37ºC. Plas-
mid DNA was added and transformation was accomplished by 20 min at 30ºC, followed by a
phenotypic expression period of 90 min at 37ºC and overnight growth on Columbia blood agar
plates supplemented with 1 μg ml-1 of tetracycline [33]. pKB01 constructs integrate by a double
cross-over into the chromosomal bgaA locus. Correct integration was verified, in single colo-
nies, by PCR. The constructed strains are listed in S1 Table.
Growth of complemented strains
Growth experiments were performed in a 96 well microtiter plate reader (Tecan Genius) in a
total volume of 200 μl C+Y medium [34], devoid of Glc and sucrose. The medium was supple-
mented with 55 mM of the desired carbon source in the presence or absence of 0.1 mM ZnCl2.
Cells were grown at 37ºC and OD595 was measured hourly.
Transcriptome analysis
For microarrays analysis, S. pneumoniae D39 was grown using Sicard’s defined medium with
or without modification [35]. Modification was done to include mucin as the sole carbon
source, replacing Glc and bovine serum albumin. Porcine gastric mucin (Sigma) was dissolved
in water at a concentration of 10 mg ml-1 and dialysed against water overnight at 4ºC using
snake skin dialysis membrane (MWCO 10 kDa, Pierce). After freeze drying, the mucin was dis-
solved in 10 mM potassium phosphate buffer, pH 7.0, autoclaved at 121ºC for 15 min. This
was then briefly centrifuged to remove insoluble residues and mixed with 2X concentrated
Sicard’s medium. The extraction of RNA was done as described previously [36,37].
Microarray experiments
Microarray slides were purchased from the Bacterial Microarray Group at St. George’s Hospital
Medical School, University of London. The SPv1.1.0 array contained spotted PCR products that
represent all of the genes in the S. pneumoniae TIGR4 and R6 genomes. The array design is
available in BμG@Sbase (accession number: A-BUGS-14; http://bugs.sgul.ac.uk/A-BUGS-14)
and also ArrayExpress (accession number: A-BUGS-14). The Materials and Methods for micro-
array analysis followed previously reported methodology [37].
Pathways for Glycan-Derived Sugars in S. pneumonia
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Analysis of microarrays
The microarray slides were scanned using an Axon GenePix 4000A microarray scanner, which
utilises GenePix 5.1 software (Molecular Devices Ltd) for identification and for a visual analysis
of the quality of the spots. The raw intensity data obtained from four independent experiments
were normalised and further analysed using GeneSpring 7.3 software (Agilent Technologies).
Data were subjected to LOWESS intensity-dependent normalisation. Statistically significant
changes in gene expression were determined as t-test p-values< 0.05 after Benjamini and
Hochberg false discovery rate correction [38]. Genes of interest were further identified by
requiring>2-fold differences in all four samples analysed. In addition, the microarray results
for selected genes whose expression significantly altered in the presence of mucin were verified
and confirmed by real time quantitative reverse transcription PCR (qRT-PCR), in order to en-
sure that dye affinity did not bias the results.
Fully annotated microarray data have been deposited in BμG@Sbase (accession number
E-BUGS-159; http://bugs.sgul.ac.uk/E-BUGS-159) and also ArrayExpress (accession number
E-BUGS-159).
Quantitative RT-PCR
To assess the expression of specific Gal catabolic genes (galT-2, galT-1, galK, lacD), by
qRT-PCR, cells were grown in CDM supplemented with the appropriate carbohydrate, as previ-
ously described, and a 4 ml aliquot was collected (16,100 x g, 2 min at 27ºC) in mid-exponential
phase of growth. The supernatant was discarded and the pellet suspended in 0.5 ml Trizol (Life
Technologies). Samples were stored at -80ºC until further analysis. RNA extraction was per-
formed as described previously [37].
To confirm the microarray results, two independent RNA preparations were used for
qRT-PCR analysis. First strand cDNA synthesis was performed on approximately 1 μg DNase-
treated total RNA, immediately after isolation, using 200 U of SuperScript II reverse transcrip-
tase (Invitrogen) and random hexamers at 42°C for 55 min [39]. cDNA (15 ng) was amplified
in a 20 μl reaction volume that contained 1 x SYBR Green PCRmaster mix (Applied Biosys-
tems) and 3 pmol of each primer (S3 Table). The transcription level of genes was normalised to
gyrB transcription, amplified in parallel with SPDRT0709F and SPDRT0709R primers. The re-
actions were performed in triplicate using the following cycling parameters with a Rotor Gene
real time PCR cycler (Qiagen): 1 cycle of 10 min 95ºC followed by 40 cycles of 30 sec 95ºC, 1
min 55°C, and 30 sec 72°C. The results were interpreted using the comparative CT method [40].
In silico analysis for catabolic pathway prediction
Potential catabolic pathways for the monosaccharides Gal, Man, GlcNAc, NeuNAc, GalNAc
and Fuc were predicted in silico by combining data obtained from the metabolic databases
MetaCyc (http://metacyc.org/META/class-tree?object=Pathways) and Kegg (http://www.
genome.jp/kegg/pathway.html), literature surveys and genome sequences. In addition, func-
tionally characterized proteins from other microorganisms were used as query for BlastP
searches of S. pneumoniae D39 genome deposited at NCBI (http://www.ncbi.nlm.nih.gov/
genome/176?project_id=58581).
Growth assay for assessment of sugar utilization by S. pneumoniae D39
The ability of monosaccharides Glc, Gal, Man, GlcNAc, glucosamine (GlcN), galactosamine
(GalN), and GalNAc to support growth of S. pneumoniae D39 was investigated using 96-well
microtiter plates containing 250 μl CDM supplemented with 30 mM of each sugar. Cultures
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were started at an initial OD595 of ~0.05 by addition of an overnight Glc-grown pre-culture pel-
leted (6300 x g, 7 min, RT) and suspended in fresh CDM without sugar. Growth was monitored
at 595 nm over 24 h at 37ºC. Readings were taken every 30 min, after 1 s shaking, using an
ELx808 Absorbance Microplate Reader (BioTek Instruments, Inc.). The growth curves were
generated by using Gen5TM (BioTek Instruments, Inc.). Each growth condition was done in
triplicate using two independent pre-cultures.
Quantification of sugar consumption and fermentation products
Strains were grown in CDM supplemented with the appropriate sugar as described above. Cul-
ture samples (2 mL) were taken immediately after inoculation and at the onset of the stationary
phase of growth, and centrifuged (16,100 x g, 3 min, 4ºC). For high performance liquid chroma-
tography (HPLC) analysis, samples were treated as described by Carvalho et al. [9]. Fermenta-
tion products and Glc were quantified by HPLC as before [9]. Gal, Man, GlcNAc and formate
were quantified by 1H-NMR and the spectra were acquired with a Bruker AMX300 spectrome-
ter (Bruker BioSpin GmbH). To quantify Gal the temperature of the probe was set to 18ºC,
whereas for Man and GlcNAc it was 37ºC. DSS (3-(trimethylsilyl) propionic acid sodium salt)
was added to the samples as an internal concentration standard in 1H-NMR quantifications.
Yields were calculated using the data from samples taken immediately after inoculation and
at the onset of stationary phase of growth. A factor of 0.38, determined from a dry weight
(DW) (mg ml-1) versus OD600 curve, was used to convert OD600 into DW (mg biomass ml
-1).
The yield in biomass was calculated as g of dry weight per mol of substrate consumed. The
ATP yield was determined as the ratio of ATP produced to substrate consumed at the time of
growth arrest assuming that all ATP was synthesized by substrate-level phosphorylation. The
values reported are averages of at least two independent growths.
Cold ethanol extractions and determination of intracellular metabolites
by 31P-NMR
For ethanol extractions, the Na2-β-glycerophosphate in the CDM growth medium was replaced
by 15.4 g l-1 MES (2-(N-morpholino) ethanesulfonic acid), to avoid the intense buffer reso-
nance in the phosphomonoester (PME) region. The ethanol extracts were prepared as de-
scribed previously by Carvalho et al. [9]. Cells were harvested (20,980 x g, 4ºC, 5 min) during
exponential growth and the pellet suspended in milliQ water, pH 6.5. Cell suspensions were
transferred to the appropriate volume of cold ethanol 70% (vol/vol) in an ice bath, and extrac-
tion was performed for 30 min with vigorous agitation. Cell debris was removed by centrifuga-
tion (39,191 x g, 4ºC, 20 min). The ethanol in the supernatant was removed via a rotavap and
the extract frozen in liquid nitrogen, and lyophilized overnight. The dried extract was dissolved
in 1 ml of deuterated water containing 5 mM EDTA. The pH was set to 6.5 and the extract was
stored at -20ºC until analysis by 31P-NMR. Resonances were assigned by addition of pure com-
pounds to the extracts or on basis of comparison with previous studies [9]. 31P-NMR spectra
were recorded using a selective probe head (31P-SEX) at 30ºC on a Bruker AVANCE II 500
MHz spectrometer (Bruker BioSpin GmbH) by using standard Bruker pulse programs. Spectra
were referenced to the resonance of external 85% H3PO4, designated at 0 ppm.
Enzyme activity determination
For enzyme activity determination, cells of S. pneumoniae were grown, in CDM supplemented
with 30 mM sugar (Gal, Man, GlcNAc or Glc), until late-exponential phase of growth, and har-
vested by centrifugation (7,519 x g, 7 min, 4ºC). The supernatant was removed, the pellet sus-
pended in cold potassium phosphate buffer (KPi) 10 mM, pH 7.0, and stored at -20ºC until
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further analysis. Dithiothreitol (1 mM) was added to the suspension and cell-free extracts pre-
pared by mechanical disruption in a French Press (6.21 MPa). Cell debris was removed (16,100
x g for 15 min, at 4ºC) and the supernatant was used for enzyme activity measurements. Ex-
tracts were kept on ice during these measurements.
For measurement of galactokinase (GalK) activity, removal of low molecular weight sub-
stances from the cell-free extract was performed using a PD-10 desalting column equilibrated
with KPi buffer 10 mM pH 7.0 according to the supplier’s instructions (GE Healthcare Life
Sciences). The GalK assay mixture contained 100 mM triethanolamine (TEA) buffer pH 7.6,
5 mMMgCl2, 10 mM ATP and 10 mM galactose. The mixture was incubated at 37ºC, in a
Thermomixer comfort (Eppendorf) and the reaction started by the addition of the cell-free ex-
tract. The reaction was stopped, at different time points, by incubating for 5 min at 85ºC and
subsequently freezing in liquid nitrogen. Samples were stored at -20ºC until further analysis.
Quantification of galactose 1-phosphate formed was accomplished by 1H-NMR spectroscopy
using a Brucker AMX300 spectrometer (Brucker BioSpin GmbH). DSS was added to the sam-
ples and used as an internal concentration standard. The slopes of the galactose 1-phosphate
(Gal1P) formed versus time were determined using linear regression.
Tagatose 1,6-diphosphate aldolase (LacD) activity was determined essentially as described
by Crow and Thomas [41]. The reaction mixture (1 ml) contained 50 mM TEA buffer pH 7.8,
0.25 mM NADH, 1.2 U α-glycerolphosphate dehydrogenase (Roche), 11.5 U triosephosphate
isomerase from rabbit muscle (Sigma-Aldrich) and 0.16 mM tagatose 1,6-diphosphate (TBP).
The oxidation of NADH was measured by the decrease in absorbance at 340 nm.
N-acetylglucosamine 6-phosphate deacetylase (NagA) activity was enzymatically assayed as
described by Homer et al. [42]. The method couples this activity to the other GlcNAc-specific
catabolic enzyme—glucosamine 6-phosphate isomerase (NagB). To ensure the applicability of
this protocol, the specific activity of NagB was measured [43]. The specific activity of this en-
zyme was higher than that of NagA for all conditions assayed, thus showing that the glucos-
amine 6-phosphate isomerase activity was not a rate limiting step. The reaction mixture (1 ml)
contained 40 mM sodium phosphate buffer pH 7.5, 1 mMN-acetylglucosamine 6-phosphate,
0.2 mM NADP+, 4 U phosphoglucose isomerase (Sigma) and 1.5 U glucose 6-phosphate dehy-
drogenase (Roche). Glucosamine 6-phosphate isomerase was measured in an identical assay
but N-acetylglucosamine 6-phosphate was replaced by glucosamine 6-phosphate. NADPH for-
mation was monitored by measuring the increase in absorbance at 340
nm spectrophotometrically.
Mannose 6-phosphate isomerase (ManA) activity was measured essentially as described
by Gracy and Noltmann [44], and modified as follows: the assay mixture contained 100 mM
TEA pH 7.6, 10 mMmannose 6-phosphate, 2 mMNADP+, 1 U of phosphoglucose isomerase
(Sigma) and 1 U of glucose 6-phosphate dehydrogenase (Roche), in a total volume of 250 μl.
The rate of change of absorbance at 340 nm (due to NADP+ reduction), coupled to mannose
6-phosphate isomerization, was measured spectrophotometrically.
The coupled enzyme protocols were carried out at 25ºC. All the reactions were started by
adding adequate amounts of freshly prepared cell-free extracts. The absorbance changes were
recorded in a Shimadzu UV-1603 spectrophotometer (Shimadzu Corporation).
One unit (U) of GalK activity is defined as the amount of protein required for the formation
of 1 μmol of Gal1P per minute. For the coupled enzyme protocols, the enzyme activity is given
as the amount of protein required to catalyse the oxidation or reduction of 1 μmol of NADH or
NADP+, respectively, per minute. Specific activity was expressed as units (μmol min-1) per mil-
ligram of protein (U mg protein-1). Protein concentration in the cell-free extracts was deter-
mined by the Pierce BCA protein assay kit (Thermo Scientific). All the determinations were
made at least in triplicate in two extracts obtained from independent cultures.
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In vivo analysis of pneumococcal strains
Ten-week-old female MF1 outbred mice (Charles River) were used. Before use, a standard in-
oculum for each pneumococcal strain was prepared as described before [39].
To assess the virulence of pneumococcal strains, mice were lightly anesthetized with 3%
(vol/vol) isoflurane over oxygen, and an inoculum of 50 μl containing approximately 1 X 106
CFU in PBS was given drop by drop into the nostrils. After infection, the inoculum dose was
confirmed by viable counting on blood agar plates. Animals were monitored for disease signs
(progressively starry coat, hunched, and lethargic) every six hours in the first 24 h. After the
onset of disease signs, which is after 24 h post-infection, the mice were monitored every 2
hours [39,45]. When the mice become lethargic, they were culled by cervical dislocation.
Therefore, time to reach lethargic state was defined as the “survival time.”Mice that were alive
7 days after infection were deemed to have survived the infection.
Colonisation experiments were done essentially as described above except that mice were
administered with 5 X 105 CFU of S. pneumoniae in 10 μl PBS. For intravenous infections, ap-
proximately 5 X 105 CFU of S. pneumoniae in 100 μl PBS (pH 7.0) were administered via a tail
vein. The inoculum dose was confirmed by plating onto blood agar, as described above.
To monitor the development of bacteraemia, approximately 20 μl of venous blood was ob-
tained from each mouse at predetermined time points after infection, and viable counts were
determined, as described above. The growth of pneumococci in the nasopharynx was also de-
termined, as described previously [39,45]. For this, at predetermined time intervals following
intranasal infection, pre assigned groups of mice were deeply anesthetized with 5% (vol/vol)
isoflurane over oxygen, and the mice were subsequently killed by cervical dislocation. Naso-
pharyngeal tissue was collected as described previously [39,45] and transferred into 10 ml of
sterile PBS, weighed, and then homogenized with an Ultra Turrax blender (Ika-Werke). Viable
counts in homogenates were determined as described above.
Survival times were calculated by using GraphPad Prism software and analysed by the
Mann-Whitney U test. Data were analysed by an analysis of variance followed by the Bonfer-
roni post-test. Statistical significance was considered to be a p-value of< 0.05.
Chemicals
N-acetylglucosamine 6-phosphate (GlcNAc6P) was obtained through a modification of estab-
lished procedures [46,47] according to S1 Fig The synthesis of tagatose 1,6-diphosphate (TBP)
is described in S2 Fig Modifications to the synthesis of TBP previously published [48] were
made in order to optimize the process (see S1 Text). The synthesized compounds were quanti-
fied by 1H-NMR, using a Brucker AMX300 spectrometer (Brucker BioSpin GmbH). DSS, used
as an internal concentration standard in 1H-NMR quantifications, was purchased fromMerck.
Galactose, mannose, and N-acetylneuraminic acid were purchased from Sigma-Aldrich.
Glucose was supplied by Merck and N-acetyl-D-galactosamine, N-acetyl-D-glucosamine, glu-
cosamine and galactosamine were purchased from Applichem. All other chemicals used were
reagent grade.
Results
Genomic potential for the utilization of host monosaccharides
Host glycans are rich in the carbohydrate monomers Gal, GalNAc, GlcNAc, NeuNAc, man-
nose (Man) and Fuc. We set out to uncover the genomic potential of S. pneumoniae D39 for
utilization of these sugars and amino sugars by performing pathway reconstruction using data
from the literature and deposited in metabolic databases (MetaCyc and Kegg), as well as by
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protein homology (BlastP) to functionally characterized enzymes (Fig 1 and S4 Table). In gen-
eral, our systematic analysis confirmed genome annotations, and a schematic representation of
the inferred sugar catabolic pathways is depicted in Fig 1. A more detailed description is pro-
vided as supplemental material (S4 Table and S2 Text).
Galactose can be metabolized via the Leloir or tagatose 6-phosphate (T6P) pathways (Fig 1),
and homologues of the genes involved in both pathways are present in the genome (S4 Table).
A duplication event of the Leloir genes, galT and galE, seems to have occurred (S4 Table), but
whether the proteins are functional is unknown. Mannose is, most likely, taken up via a PTS [8]
and the phosphorylated product isomerised to fructose 6-phosphate (F6P) via mannose
6-phosphate isomerase. Complete pathways for utilization of GalNAc and Fuc could not be suc-
cessfully reconstituted using the tools in this work. S. pneumoniaeD39 also possesses homo-
logues of all proteins involved in the bacterial superpathway for the dissimilation of the amino
sugars N-acetylneuraminate and GlcNAc (S4 Table and S2 Text) [49].
The ability of host glycan-derived sugars to support growth is sugar
dependent
The presence of the genes for a full metabolic pathway in the genome does not confirm that the
pathway is functioning. Thus, we assessed the ability of monosaccharide constituents of host
glycans to support growth of S. pneumoniae D39 in a chemically defined medium (Fig 2). Of
the monosaccharides tested, growth was observed on glucosamine, GlcNAc, Gal and Man. In
contrast, S. pneumoniae was unable to use GalNAc, galactosamine (Fig 2) and NeuNAc (data
not shown) as single carbon sources for growth. Fucose was not tested, since inability to grow
in this sugar has been previously documented [8,50–52]. The ability of each sugar to sustain
growth was consistent with the conclusions from genome analysis.
Mucin induces expression of genes involved in utilization of Gal, GlcNAc
and Man
Mucins are the most abundant glycoproteins in the human respiratory tract, and S. pneumo-
niae is capable of growing on mucin as sole carbon source [12]. To reveal prevalent pathways
during growth on mucin, we performed a whole transcriptome analysis comparing the mRNA
levels of S. pneumoniae D39 cells grown on porcine gastric mucin to those of cells grown on
Glc (see Materials and Methods). The assumption for this experimental design was that genes
potentially involved in the utilization of sugar moieties in mucin would be upregulated. In line
with this hypothesis, 39 out of 83 genes that were significantly differentially expressed (accord-
ing to the established criterion) encode for proteins with predicted functions in sugar process-
ing (modification, uptake and catabolism) (Table 1).
Seven of the upregulated genes were involved in the hydrolysis of sugars (Table 1). Of note,
bgaA encoding a β-galactosidase, the activity of which results in free Gal, showed the highest
differential expression value. strH, which codes for a β-N-acetylhexosaminidase, involved in
the hydrolysis of terminal non-reducing N-acetyl-D-hexosamine residues, was the second
most upregulated glycosidase (Table 1).
Among the genes implicated in sugar processing (Table 1), 49% encode components of PTS
or ABC transporters. Three genes encoding a complete PTS in the galactitol family, and pre-
sumably involved in Gal uptake [8,53], showed a high positive response to mucin. In the ge-
nome of D39, this Gat-PTS transport system is located upstream of the bgaA locus. Also,
highly overexpressed was the Man-PTS family transporter (SPD_0066-8-9) presumably in-
volved in Gal and Man transport (Table 1 and S4 Table) [8]. In fact, genes putatively involved
in Man uptake represented the highest fraction of transport systems upregulated in the
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presence of mucin (Table 1 and S4 Table). Moreover, a gene (SPD_1496) presumed to be in-
volved in the translocation of GlcNAc was found differentially overexpressed (Table 1 and
S4 Table), in accordance with the observed upregulation of strH. Mucin also induced the ex-
pression of genes potentially involved in NeuNAc uptake (Table 1 and S4 Table).
Fig 1. Schematic representation of the proposed pathways for the dissimilation of monosaccharides originating from deglycosylation of host
glycans in S. pneumoniaeD39. Pathways were reconstructed resorting to metabolic databases (MetaCyc and KEGG), genome annotations at NCBI and
literature. Genes and intermediates involved in the galactose (Gal), mannose (Man), N-acetylneuraminic acid (NeuNAc), N-acetylgalactosamine (GalNAc),
N-acetylglucosamine (GlcNAc) and fucose (Fuc) catabolism are shown. Initial steps of glycolysis are depicted. galM, aldolase 1-epimerase; galK,
galactokinase; galT-1, galT-2, galactose 1-phosphate uridylyltransferase; galE-1, galE-2, UDP-glucose 4-epimerase; pgm, phosphoglucomutase/
phosphomannomutase family protein; lacA, galactose 6-phosphate isomerase subunit LacA; lacB, galactose 6-phosphate isomerase subunit LacB; lacC,
tagatose 6-phosphate kinase; lacD, tagatose 1,6-diphosphate aldolase;manA, mannose 6-phosphate isomerase; SPD_1489, SPD_1163, N-
acetylneuraminate lyase; SPD_1488, ROK family protein, nanE-1, nanE-2, N-acetylmannosamine 6-phosphate 2-epimerase; nagA, N-acetylglucosamine
6-phosphate deacetylase; nagB, glucosamine 6-phosphate isomerase; fucI, L-fucose isomerase; fucK, L-fuculose kinase; fucA, L-fuculose phosphate
aldolase. α-Gal, α-galactose; α-Gal1P, α-galactose 1-phosphate; α-G1P, α-glucose 1-phosphate; UDP-Glc, UDP-glucose; UDP-Gal, UDP-galactose;Gal6P,
galactose 6-phosphate; T6P, tagatose 6-phosphate; TBP, tagatose 1,6-diphosphate;Man6P, mannose 6-phosphate;ManNAc, N-acetylmannosamine;
ManNAc6P, N-acetylmannosamine 6-phosphate;GlcNAc6P, N-acetylglucosamine 6-phosphate;GlcN6P, glucosamine 6-phosphate; Fucl, fuculose;
Fucl1P, fuculose 1-phosphate;GalNAc6P, N-acetylgalactosamine 6-phosphate; GalN6P, galactosamine 6-phosphate. The upper glycolytic intermediates
and gene annotations are as follows:G6P, glucose 6-phosphate; F6P, fructose 6-phosphate; FBP, fructose 1,6-biphosphate;GAP, glyceraldehyde
3-phosphate; DHAP, dihydroxyacetone phosphate. gki, glucokinase; pgi, glucose 6-phosphate isomerase; pfkA, 6-phosphofructokinase; fba, fructose-
biphosphate aldolase; tpiA, triosephosphate isomerase. The lower glycolytic pathway is represented by a dashed arrow. Pathways or steps present in other
organisms but uncertain in D39 are represented in grey. Vertical arrows near the gene name indicate the upregulation during growth on mucin as compared
to Glc, in S. pneumoniaeD39.
doi:10.1371/journal.pone.0121042.g001
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Finally, genes involved in both Gal catabolic routes, lacAB and lacD of T6P pathway and
galM of the Leloir pathway were highly overexpressed during growth on mucin (Table 1 and
Fig 1). Expression levels of selected genes, obtained by qRT-PCR, confirmed the transcriptome
results (S6 Table).
In summary, our transcriptome analysis revealed that mucin induced the expression of
genes required to benefit from Gal, GlcNAc and Man residues present in host glycans. Capital-
izing on the growth and expression data, we surmised that these sugars are important carbon
sources for D39 during colonisation of the nasopharynx. Hence, we set out to characterize
growth and validate predicted metabolic pathways for utilization of Gal, GlcNAc and Man.
Growth properties on Gal, GlcNAc and Man or on a mixture thereof
Growth parameters and fermentation end-products were determined in batch cultures of S.
pneumoniae D39 using chemically defined medium and two concentrations of Gal, GlcNAc or
Man: 13±1 mM and a higher non-limiting 34±2 mM.
Growth profiles on Gal, Man and GlcNAc. Representative growth profiles (experimental
data) and model 95% confidence and prediction curves that best describe the growth data are
depicted in Fig 3. In general, the model fits well with the experimental data. The 95% confi-
dence curves (Fig 3) reveal that the larger differences between biological growth replicas occur
at the final stage of the growth, as shown by higher discrepancies in the final optical density
(ODmax) rather than specific growth rate (μmax). The parameters derived from the growth anal-
ysis are shown in Table 2. Analysis through ANOVA and pairwise t-tests allowed assessment
of the statistical significance of the growth parameter differences across the experimental con-
ditions (S2 Table).
In medium containing the higher substrate concentration, GlcNAc supported a significantly
faster growth than Gal and Man (Table 2 and S2 Table). However, no significant differences
Fig 2. Growth of S. pneumoniae D39 in glycan-derived sugars.Growth profiles of D39 grown in CDM
supplemented with 30 mM of galactose (Gal), mannose (Man), N-acetylglucosamine (GlcNAc), glucosamine
(GlcN), N-acetylgalactosamine (GalNAc), galactosamine (GalN) and glucose (Glc). Growth experiments
were performed at 37ºC and at an initial of pH 6.5, using a 96-well microtiter plate reader. Symbols: (closed
circle) Glc; (closed triangle) GlcNAc; (open diamond) GlcN; (open square) Gal; (closed diamond) Man, (dash)
GalNAc and (open circle) GalN. Growth curves are plotted in decimal scale to assess for significant
differences in the growth profiles.
doi:10.1371/journal.pone.0121042.g002
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(p = 0.15) were found between cells growing on higher concentrations of Gal or Man, with the
specific growth rate similar in both conditions (Table 2 and S2 Table). In contrast, for the
lower substrate concentration, the growth rate was sugar dependent with the amino sugar sup-
porting a significantly higher growth rate than Man or Gal (Table 2 and S2 Table). The specific
Table 1. Expression levels of genes upregulated in S. pneumoniae D39 cells grown in mucin as compared to glucose-grown cells a,b.
Locus-tag Gene Function Overexpression fold
SPD_0562 bgaA Beta-galactosidase 71.8
SPD_1057 PTS system transporter subunit IIB 61.3
SPD_0561 PTS system transporter subunit IIC 45.5
SPD_0068 PTS system transporter subunit IID 25.4
SPD_1053 lacA Galactose 6-phosphate isomerase subunit LacA 24.5
SPD_0069 PTS system transporter subunit IIA 23.9
SPD_1052 lacB Galactose 6-phosphate isomerase subunit LacB 21.7
SPD_0071 galM Aldose 1-epimerase 19.4
SPD_1050 lacD Tagatose 1,6-diphosphate aldolase 17.6
SPD_0559 PTS system transporter subunit IIA 15.1
SPD_0560 PTS system transporter subunit IIB 12.1
SPD_1494 Sugar ABC transporter permease 10.3
SPD_0070 agaS Sugar isomerase 9.8
SPD_0063 strH Beta-N-acetylhexosaminidase 8.7
SPD_1663 treC Alpha,alpha-phosphotrehalase 8.0
SPD_0066 PTS system transporter subunit IIB 7.8
SPD_0287 Hyaluronate lyase 7.7
SPD_1495 Sugar ABC transporter sugar-binding protein 6.7
SPD_0293 PTS system transporter subunit IIA 6.5
SPD_1834 Bifunctional acetaldehyde-CoA/alcohol dehydrogenase 5.8
SPD_0292 Gluconate 5-dehydrogenase 5.3
SPD_1409 Sugar ABC transporter ATP-binding protein 4.8
SPD_1934 malX Maltose/maltodextrin ABC transporter maltose/maltodextrin-binding protein 4.8
SPD_0297 PTS system transporter subunit IID 4.4
SPD_1496 PTS system transporter subunit IIBC 4.4
SPD_1006 glgC Glucose 1-phosphate adenylyltransferase 4.4
SPD_0621 lctO Lactate oxidase 4.0
SPD_1935 malC Maltodextrin ABC transporter permease 3.9
SPD_0420 pﬂB Formate acetyltransferase 3.7
SPD_1007 glgD Glucose 1-phosphate adenylyltransferase, GlgD subunit 3.5
SPD_1005 glgB Glycogen branching protein 2.9
SPD_1936 malD Maltodextrin ABC transporter permease 2.9
SPD_0250 Pullulanase, extracellular 2.9
SPD_1989 PTS system transporter subunit IID 2.6
SPD_0427 lacG-1 6-phospho-beta-galactosidase 2.5
SPD_1675 rafG Sugar ABC transporter permease 2.4
SPD_0925 Hydrolase 2.4
SPD_1937 malA Maltodextrose utilization protein MalA 2.3
SPD_0424 PTS system cellobiose-speciﬁc transporter subunit IIC 2.2
a Only genes potentially involved in sugar hydrolysis, uptake and metabolism are shown. Hypothetical proteins have been omitted.
b For a complete appreciation a full list of the signiﬁcantly differentially expressed genes is provided in S5 Table.
doi:10.1371/journal.pone.0121042.t001
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Fig 3. Representative growth profiles of S. pneumoniae D39 grown in CDM in the presence of two different concentrations of galactose (Gal), N-
acetylglucosamine (GlcNAc), mannose (Man) or glucose (Glc).Growth profiles in 80 ml batch cultures using (A) excess substrate concentration (34±2
mM) and (B) a 3-fold lower initial substrate concentration (13±1 mM). Representative growth curves (empty dots) were selected based on the established
criterion (see Materials and Methods). The experimental data was fitted using the Gompertz model with all replicates (estimated curve in black dashed line)
and the 95% confidence bands (small dashed light grey lines) and 95% predicted bands (big dashed dark grey lines) were determined (see Materials and
Methods). Growth was performed at 37ºC, under semi-anaerobic conditions, without pH control (initial pH 6.5). Growth curves are plotted in decimal scale to
allow the visual discernment between significantly differences in the growth parameters using the two initial substrate concentrations.
doi:10.1371/journal.pone.0121042.g003
Table 2. Growth and energetic parameters of S. pneumoniaeD39 on sugars present in host glycans.
GlcNAc Gal Man Glc Mix
[substrate]initial (mM) 30.8±0.6 12.3±0.6 33.7±1.5 13.4±1.3 33.4±0.3 12.4±0.1 34.2±1.8 12.9±0.4 6.5±0.3
a
µmax (h-1) 0.55±0.06 0.54±0.08 0.48±0.04 0.32±0.03 0.45±0.04 0.44±0.04 0.93±0.07 0.93±0.09 0.61±0.05
0.07±0.01b
OD600max 1.76±0.25 0.99±0.08 2.16±0.12 1.12±0.26 1.77±0.16 1.03±0.08 2.29±0.17 1.06±0.04 1.19±0.11
ΔpH 1.10±0.08 0.41±0.05 1.02±0.06 0.48±0.07 1.23±0.15 0.44±0.03 1.28±0.09 0.44±0.03 0.57±0.08
Substrate Consumed (%) 93±6 100±0 69±9 84±7 87±10 100±0 92±4 100±0 86±2
Substrate Recovery 87±5 84±3 72±1 76±9 85±9 89±3 86±5 84±2 79±3
Redox Balance 86±5 83±3 70±2 75±5 85±9 85±3 85±5 82±1 81±4
ATP yield (mol mol-1
substrate)
1.77±0.09 1.74±0.08 2.08±0.03 2.27±0.31 1.80±0.21 1.98±0.04 1.75±0.11 1.71±0.04 1.73±0.06
YATP (g biomass mol-1ATP) 12.1±0.7 16.8±0.9 17.5±1.4 14.9±0.5 13.6±1.4 16.2±0.4 15.3±0.8 18.8±0.0 16.4±0.4
Ybiomass (g mol-1
substrate)
21.4±2.4 29.3±2.9 36.3±2.4 34.1±5.8 24.3±0.3 31.9±0.1 26.7±0.3 32.0±0.8 28.3±1.8
Growth rate, maximal biomass, yields, carbon and redox balances, substrate consumed and variation of pH were obtained for S. pneumoniae D39 grown
in CDM in the presence of N-acetylglucosamine (GlcNAc), galactose (Gal), mannose (Man) and glucose (Glc) using two substrate concentrations or in a
mixture of Gal, Man and GlcNAc (circa 6.5 mM each). Growth was performed at 37ºC without pH control (initial pH 6.5). Values represent the average and
standard deviation of at least two independent growth experiments and are estimated at the time point of growth arrest (maximal biomass).
aThe value represents the average ± standard deviation of the concentration of sugars present in the mixture. Individual values are: Gal, 6.4±0.7 mM;
Man, 6.6±0.1 mM and GlcNAc, 6.7±0.2 mM.
bSecond speciﬁc growth rate.
ΔpH is the difference between the initial pH and the pH at the time of growth arrest; substrate recovery is the percentage of carbon in metabolized sugar
that is recovered in the fermentation products (lactate, ethanol, acetate, and formate); redox balance is the ratio between [lactate]+2×[ethanol] and
2×[substrate consumed] multiplied by 100.
doi:10.1371/journal.pone.0121042.t002
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growth rate is independent of the initial substrate concentration (Table 2), except for Gal
which supports higher growth rates when the substrate is in excess. The involvement of a low
affinity transporter in the uptake of this sugar would explain this behaviour.
When the higher substrate concentration was used, Gal supported the highest final biomass,
which was similar to that on Glc (p = 0.06) (Table 2 and S2 Table). No significant differences in
the final biomass (p = 0.89) were observed between growths on GlcNAc and Man, which were
lower than that on Gal (Table 2 and S2 Table). At the lower substrate concentration the bio-
mass formed was similar for the glycan-derived sugars and Glc, and unsurprisingly lower than
those obtained using non-limiting sugar concentrations (Fig 3, Table 2 and S2 Table).
In medium with Gal, growth arrest occurred before substrate depletion, even for the low Gal
concentration (Table 2). For the higher sugar concentrations, a pH decrease of about one unit
was observed at the onset of stationary phase, which is consistent with growth arrest due to
acidification. However, the observed change in pH of 0.5 units does not explain the arrest of
growth in the lower Gal concentration. Even though a full explanation cannot be put forward,
the possession of only low-affinity Gal importers can be proposed as a cause for growth slow-
down with decreasing Gal concentrations.
Fermentation products. End-products resulting from the fermentations of Gal, GlcNAc
and Man are shown in Table 3. S. pneumoniae displayed a fully homolactic fermentation pro-
file when GlcNAc was the sole carbon source, regardless of the initial concentration. In addi-
tion to lactate, acetate, ethanol and formate were produced as minor fermentation products
(Table 3). On Man, the fermentation profile was still mainly homolactic. However, a shift to-
wards mixed acid fermentation was evident, accounting for 9% and 17% of the substrate con-
sumed in the higher and lower substrate concentrations, respectively. In contrast, cells grown
on Gal showed a pronounced mixed acid fermentation (Table 3), independently of the initial
concentration of sugar. Formate, ethanol and acetate were produced in the ratio 2:1:1, as ex-
pected from mixed acid fermentation under anaerobic conditions. Lactate was detected as a
minor fermentation product, accounting for 8% and 2% of the consumed Gal, for the higher
and lower substrate concentration, respectively (Table 3). The shift towards mixed acid fer-
mentation profile was generally higher for the lower substrate concentrations.
The calculated values for substrate recovery are in good agreement with fermentative me-
tabolism (above 80%). On Gal, carbon balances in the 70% range were determined, indicating
an additional carbon sink (Table 2).
Growth profiles, substrate consumption and end-products of fermentation in a mixture
of Gal, GlcNAc and Man. In its ecological niche, S. pneumoniae is exposed to a multiplicity of
Table 3. End-products derived from the catabolism of N-acetylglucosamine (GlcNAc), galactose (Gal), mannose (Man) and glucose (Glc) by S.
pneumoniae D39, using 34±2 mM or 13±1 mM initial substrate concentrations.
Higher substrate concentration Lower substrate concentration
Sugar GlcNAc Man Gal Glc GlcNAc Man Gal Glc
[End-products] (mM)
Lactate 49.02±8.19 43.80±0.11 3.88±0.54 53.10±1.59 19.42±0.35 17.27±1.63 0.50±0.00 20.93±0.29
Acetate 0.92±0.10 2.68±0.17 14.91±1.24 0.83±0.38 0.79±0.14 2.44±0.26 8.43±0.06 0.46±0.12
Ethanol 0.48±0.08 2.66±1.67 14.30±1.53 0.10±0.04 0.42±0.11 1.64±0.43 8.16±0.86 0.08±0.02
Formate 1.62±0.43 5.10±0.75 29.43±1.85 BDL 1.82±0.73 3.77±0.44 16.53±0.84 BDL
Growth was done in CDM supplemented with the appropriate sugar, at 37ºC, under semi-anaerobic conditions, without pH control (initial pH 6.5). The
results represent averages of at least two experiments and the error bars the standard deviation.
BDL, below detection limit. In glucose grown cells, formate was produced, but in quantities below the limit of quantiﬁcation.
doi:10.1371/journal.pone.0121042.t003
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sugars. Thus, we set out to evaluate growth on a sugar mixture containing Gal, GlcNAc and Man.
An initial concentration of approximately 6.5 mM for each carbohydrate, was tested (Fig 4). On
the sugar mixture, S. pneumoniaeD39 displayed a biphasic growth profile. The maximal growth
rate (μ1) was observed within the first 4 h of growth and was about nine times higher than the
second growth rate (μ2) (Fig 4A). Interestingly, μ1 was similar to that determined in the presence
of the lower concentration of GlcNAc alone (Table 2), suggesting that this sugar was
consumed first.
The profile of sugar utilization was determined by measuring the sugars in the culture medi-
um using 1H-NMR (Fig 4C). We confirmed that GlcNAc was consumed first and was totally
depleted after 6 h of growth. Consumption of Man started while GlcNAc was still available,
and its depletion occurred 8 h after inoculation. Interestingly, Gal was only used after depletion
of GlcNAc and Man. This is in good agreement with the two distinct growth rates found: the
first is related to GlcNAc and Man consumption, whereas the second mostly reflects the utiliza-
tion of Gal.
In the sugar mixture, the end-products profile was mainly homolactic, with lactate as the
major product (21.2 ± 0.5 mM) (Fig 4B). Minor quantities of formate, ethanol and acetate were
formed in a proportion of 2:1:1. (Fig 4B). Growth arrest was most likely not due to acidifica-
tion, since only a modest change in pH (ΔpH) was registered (Table 2). On the other hand, Gal
was not fully consumed, with approximately 40% remaining in the medium at the time of
growth arrest (12 h after inoculation) (Table 2 and Fig 4C). A similar behaviour was observed
when Gal was used as single carbon source. These results demonstrated that S. pneumoniae
D39 is able to metabolize different carbon sources simultaneously or sequentially. In a mixture
consisting of 6.5 mM GlcNAc, Man and Gal, strain D39 had a preference for GlcNAc, but
could use Man concurrently. Gal was the least preferred sugar, and was only consumed after
exhaustion of the two other carbon sources.
Catabolic pathways for the utilization of Gal, GlcNAc and Man as
assessed using biochemical and molecular tools
Experimental confirmation of the predicted metabolic routes for the catabolism of Gal, Man
and GlcNAc was performed at the biochemical level through metabolite profiling by 31P-NMR
Fig 4. Growth profile of D39 in a mixture of galactose (Gal), mannose (Man) and N-acetylglucosamine (GlcNAc). (A) Representative growth curve of
S. pneumoniaeD39 grown in CDM supplemented with a mixture of Gal, GlcNAc and Man (6.5 mM each), at 37ºC, under semi-anaerobic conditions, without
pH control (initial pH 6.5). (B) End-products of fermentation derived from the catabolism of the sugars in the mixture (Gal, Man and GlcNAc), determined at
the time of growth arrest (maximal biomass). (C) Gal, Man and GlcNAc consumption, over time, during the growth of S. pneumoniaeD39 in CDM. The values
are percentages of the initial sugar concentration for each sugar. The representative growth curve was selected based on the established criterion (see
Materials and Methods). The results represent averages of two independent growths and the error bars represent the standard deviation.
doi:10.1371/journal.pone.0121042.g004
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and enzyme activity measurements, and at the genetic level by mutating key genes in
the pathways.
Intracellular metabolites during growth on glycan-derived sugars. Ethanol extracts of
growing cells were examined for phosphorylated intermediates of catabolic pathways by tar-
geted metabolomics using 31P-NMR. In extracts derived from S. pneumoniae D39 Gal-grown
cells, phosphorylated intermediates of the Leloir pathway, α-galactose 1-phosphate (α-Gal1P)
and α-glucose 1-phosphate (α-Glc1P), as well as phosphorylated metabolites involved in the
T6P pathway: galactose 6-phosphate (Gal6P) and tagatose 1,6-diphosphate (TBP), were de-
tected (Fig 5), indicating the active presence of both catabolic routes for Gal catabolism. These
data are in agreement with an earlier report for a different isolate of S. pneumoniae strain D39
[9]. The accumulation of mannose 6-phosphate (Man6P) during growth on Man is a strong in-
dication of the functioning of the predicted catabolic route (Figs 1 and 5). The intracellular in-
termediates predicted in the catabolic pathway of GlcNAc, N-acetylglucosamine 6-phosphate
(GlcNAc6P) and glucosamine 6-phosphate (GlcN6P), were detected in the extracts of cells
grown on this carbon source (Figs 1 and 5). Surprisingly, fructose 6-phosphate (F6P) was high-
ly accumulated under this condition.
Thus, the occurrence of specific phosphorylated metabolites in cell extracts correlated well
with the predicted metabolic intermediates in the catabolism of each sugar.
Enzymatic activities of key enzymes involved in the catabolism of glycan-derived sug-
ars. To further substantiate the functioning of the predicted pathways, we selected enzymes
presumed to be required for pathway activity, galactokinase (GalK, SPD_1634) and tagatose
1,6-diphosphate aldolase (LacD, SPD_1050) for Gal, mannose 6-phosphate isomerase (ManA,
SPD_0641) for Man and N-acetylglucosamine 6-phosphate deacetylase (NagA, SPD_1866) for
GlcNAc, and determined their specific activities using specific biochemical assays (see Materi-
als and Methods).
On galactose, the specific activities of GalK and LacD in cell-free extracts of D39 were con-
siderably higher than those measured on Glc-grown cells (Table 4), suggesting induction of the
pathway on Gal. These data are consistent with the functioning of both pathways during
growth on Gal. The GalK specific activity was higher than the LacD specific activity, under the
conditions assayed (Table 4).
The specific activity of N-acetylglucosamine 6-phosphate deacetylase (NagA), the enzyme
dedicated to GlcNAc catabolism, was 2-fold higher when grown on GlcNAc than in Glc-grown
cells (Table 4). The method to assay NagA, couples its activity to that of glucosamine 6-phos-
phate isomerase (NagB). The latter was not limiting in the assay, since its specific activity was 4
times higher than that of NagA (data not shown).
The key enzyme of the Man catabolic pathway, ManA, was detected in Man-grown cells,
but the level was only marginally reduced (30%) in Glc-grown cells (Table 4).
In summary, enzyme activities of dedicated sugar catabolic enzymes were detected for each
metabolic pathway assayed, indicating the operability of the dissimilation routes proposed.
Genetic confirmation of pathway functionality. The biochemical approach to investigate
the Gal, Man and GlcNAc catabolic pathways was complemented by a genetic approach. Mu-
tants in key enzymatic steps of each catabolic route were constructed by allelic replacement
mutagenesis, yielding D39ΔgalK, D39ΔlacD, D39ΔmanA and D39ΔnagA (S3 Fig). The muta-
tions were confirmed by growth profiles and enzyme activity measurement (Table 4 and Fig 6).
The deletion mutants lost the activity encoded by the inactivated gene, except for the
D39ΔmanA mutant (Table 4). In Glc-grown D39ΔmanA, the activity of mannose 6-phosphate
isomerase showed a 43% and 60% reduction compared to that in Glc- or Man-grown wild type
D39 cells, respectively (Table 4).
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Fig 5. Phosphomonoester region of 31P-NMR spectra of ethanol extracts obtained in late-exponential cells of S. pneumoniaeD39 grown in CDM
with galactose (Gal), mannose (Man) or N-acetylglucosamine (GlcNAc). Ethanol extracts of glucose (Glc) grown cells were used as control. The
glycolytic intermediates fructose 1,6-biphosphate (FBP), glucose 6-phosphate (G6P) and 3-phosphoglycerate (3-PGA) were firmly assigned. Abbreviations:
αGal1P, α-galactose 1-phosphate; αGlc1P, α-glucose 1-phosphate; TBP, tagatose 1,6-diphosphate; Gal6P, galactose 6-phosphate; Man6P, mannose
6-phosphate; GlcN6P, glucosamine 6-phosphate; GlcNAc6P, N-acetylglucosamine 6-phosphate and F6P, fructose 6-phosphate. Identification of
phosphorylated intermediates was performed by spiking the ethanol extracts with pure compounds. Symbols: (asterisk) FBP, (closed square) G6P, (open
diamond) 3-PGA.
doi:10.1371/journal.pone.0121042.g005
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Importantly, the D39ΔmanA or D39ΔnagA strains were unable to use Man or GlcNAc as
sole carbon source, respectively (Fig 6C and 6D). D39ΔlacD was able to grow on Gal, although
only after a lag period of circa 20 h (Fig 6B). A mutant in both Gal catabolic pathways was con-
structed, D39ΔlacDΔgalK, which lost the ability to grow on this monosaccharide. Unexpected-
ly, inactivation of galK alone resulted in a strain unable to grow on Gal, even though the T6P
pathway was still intact (Fig 6A). All pathway-specific mutants were able to grow on sugars
other than the substrate of the targeted catabolic pathway (Fig 6). To ensure that growth abro-
gation was unrelated to possible polar effects, complementation studies were conducted (see
Materials and Methods, S4 Fig). D39ΔmanA and D39ΔlacD complemented withmanA and
lacD under the Zn2+-inducible promoter (PczcD) [54], had fully restored growth on Man and
Gal, respectively. It is worth noting that growth on Man was better in the complemented
D39ΔmanA as compared to wild type D39, suggesting that the ManA activity level might be a
limiting factor for Man utilization (S4D Fig). For the D39ΔnagA, the ability to grow on GlcNAc
was recovered by expressing, in trans, nagA under its own promoter (S4C Fig).
For D39ΔgalK, the ability to grow on Gal was not recovered by complementation in trans
with galK. RNA-Seq data [55] showed that galK is co-transcribed with the downstream gene
galT-2 and a polar effect of the galK deletion on galT-2 is therefore possible (S3 Fig). Indeed,
the growth phenotype on Gal could be restored by complementation in trans with galKgalT-2
(S4A Fig). Importantly, complementation with galT-2 alone was not successful, suggesting that
abrogation of growth on Gal is a consequence of galK inactivation.
To further analyse the effect of gene deletions in the Leloir pathway, a D39ΔgalT-2mutant
was constructed. The D39ΔgalT-2 grew on Gal, but the time to reach maximal biomass was
2.3-fold longer as compared to the wild type (data not shown). This result indicates the occur-
rence of an alternative galactose 1-phosphate activity, likely to be encoded by galT-1. On Gal, the
expression level of galT-1 in D39ΔgalT-2 was 49-fold higher than in D39, as shown by qRT-PCR
(S7 Table). Expression of lacD was 87-fold higher in Gal-grown D39ΔgalT-2 (S7 Table) than in
Table 4. Enzyme specific activities determined in extracts of S. pneumoniae derived from cells grown to late-exponential phase of growth in CDM
supplemented with different monosaccharides.
Speciﬁc activities (U mg protein-1)
Strain Growth condition (carbon source) GalK LacD NagA ManA
D39 Gal 0.89 ± 0.11 0.08 ± 0.01 - -
D39 GlcNAc - - 0.04 ± 0.00 -
D39 Man - - - 0.10 ± 0.01
D39 Glc BDL BDL 0.02 ± 0.00 0.07 ± 0.01
D39ΔgalK Glc BDL - - -
D39ΔlacD Gal - BDL - -
D39ΔnagA Glc - - BDL -
D39ΔmanA Glc - - - 0.04 ± 0.01
Speciﬁc activity is expressed as units (U) (μmol min-1) per milligram of protein (U mg protein-1).
GalK speciﬁc activity is deﬁned as the amount of protein required for the formation of 1 μmol of Gal1P min-1 mg protein-1. LacD speciﬁc activity is given as
the amount of protein required to catalyse the oxidation of 1 μmol of NADH min-1 mg protein-1. NagA and ManA speciﬁc activities are the amount of
protein to reduce 1 μmol of NADP min-1 mg protein-1. The values reported represent averages ± standard deviation obtained in cell-free extracts of at least
two independent cultures.
-, not determined.
BDL, below detection limit.
doi:10.1371/journal.pone.0121042.t004
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Gal-grown wild type, indicating that in the D39ΔgalT-2mutant the lac operon is expressed and
the T6P pathway is active.
Attenuated virulence in the absence of a functional Gal pathway
The contribution of genes encoding proteins involved in catabolism of host-derived glycans
was tested in mouse models of colonisation, and of models of bronchopneumonia with bacter-
aemia that result from intranasal infection. While the bronchopneumonia model allows evalua-
tion of factors that are important for acute infection and invasiveness, the colonisation model
is ideal to evaluate the determinants of longer term pneumococcal survival in vivo [56].
Mice infected with the mutants in Gal catabolic pathways survived significantly longer than
wild type D39 strain in the bronchopneumonia model (Fig 7A) (average survival time of mice
infected with: D39 44±30.7 h, n = 20; D39ΔgalK 60±36.3 h, n = 10; D39ΔlacD 59±54.1 h,
n = 10 and D39ΔlacDΔgalK 123±55.8 h, n = 10; p<0.01 for D39ΔgalK, and p<0.001 for
D39ΔlacD and D39ΔlacDΔgalK; Mann-Whitney U test). In addition, reintroduction of an in-
tact copy of galK and lacD into D39ΔgalK and D39ΔlacD, respectively, reconstituted the viru-
lence of these strains with the median survival times of mice infected with D39ΔgalKcomp
(44±40.3 h, n = 10) and D39ΔlacDcomp (51.2±40.3 h, n = 10), not significantly different from
Fig 6. Growth profile of D39 sugar-specific mutants.Growth phenotypes of (A) D39ΔgalK, (B) D39ΔlacD, (C) D39ΔnagA and (D) D39ΔmanA. Growth
was performed in CDM supplemented with galactose (Gal), N-acetylglucosamine (GlcNAc), mannose (Man) or glucose (Glc), using the 96-well microplate
reader. Symbols: (closed triangle) GlcNAc; (closed diamond) Man; (open square) Gal and (closed circle) Glc.
doi:10.1371/journal.pone.0121042.g006
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the wild type infected cohort (p>0.05). This shows that the observed reduction in virulence
was not due to polar effect of mutations.
The progression of bacteraemia in animals infected with the pneumococcal strains was also
determined. At 24 h post-infection mice infected either with D39ΔgalK (log10 3.10±0.7,
n = 10), D39ΔlacD (log10 3.54±0.6, n = 10), or D39ΔlacDΔgalK (log10 2.23±0.75, n = 10) had
significantly lower mean CFU ml-1 of bacteria in the blood than that of the wild type infected
cohort (log10 5.21±0.4, n = 20) (p<0.01 for D39ΔgalK, p<0.05 for D39ΔlacD, and p<0.001 for
D39ΔlacDΔgalK) (Fig 7B). At 48 h post-infection, the blood bacterial counts recovered from
D39ΔlacDΔgalK (log10 3.48±1.16, n = 10) infected cohort was still significantly lower than that
of the wild type infected (log10 7.76±0.48, n = 20) (p<0.001), however, the numbers of
D39ΔgalK (log10 6.53±0.81, n = 10) and D39ΔlacD (log10 5.92±1.13, n = 10) were similar to the
wild type (p>0.05). Furthermore, no significant difference could be detected in the numbers of
D39ΔgalKcomp (24 h: log10 4.47±0.64 and 48 h: log10 6.86±0.82 n = 10), D39ΔlacDcomp (24 h:
log10 3.81±0.86 and 48 h: log10 5.59±1.24 n = 10), and the wild type at 24 and 48 h post-infec-
tion (p>0.05). D39ΔmanA and D39ΔnagA were also tested in bronchopneumonia model,
however, the virulence properties of these strains were similar to the wild type (data not
shown).
In the colonisation model, the counts for all the pneumococcal strains were determined in
nasopharyngeal tissue at the time of infection, and at 3 and 7 days after infection (Fig 8). The
results show that at 3 and 7 days post-infection the numbers of D39ΔgalK (log10 1.75±0.14 and
log10 1.80±0.17 n = 5), D39ΔlacD (log10 1.72±0.2 and log10 1.87±0.24, n = 5), and D39ΔlacDΔ-
galK (log10 1.08±0.33 and log10 0.89±0.25, n = 5) were significantly lower than the counts of
wild type (log10 2.82±0.02; and log10 2.77±0.08, n = 5, for days 3 and 7, respectively) (p<0.01
for D39ΔgalK, p<0.0001 for D39ΔlacDΔgalK, and p<0.01 and p<0.05 for D39ΔlacD for 3 and
7 days post-infection, respectively). Similar to the bronchopneumonia model, in the colonisa-
tion model no phenotypic differences were observed between the wild type and
Fig 7. Impaired virulence of pneumococcal strains defective in galactose catabolic pathways following intranasal infection. (A) Survival time of mice
after infection with approximately 1 X 106 CFU pneumococci. Symbols show the times mice became severely lethargic. The horizontal bars mark the median
times to the severely lethargic state. (B) Growth of bacteria in the blood. Each point is the mean of data from ten mice except for D39, which represents 20
mice. Error bars show the standard error of the mean. Symbols: * p<0.05; ** p<0.01; *** p<0.001.
doi:10.1371/journal.pone.0121042.g007
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D39ΔgalKcomp, D39 ΔlacDcomp (Fig 8) (p>0.05), and the wild type and D39 ΔmanA and
D39 ΔnagA (data not shown).
In addition to respiratory infection models, we also tested all the strains in a bacteraemia
model through direct administration of bacteria through a tail vein in order to distinguish
niche-specific contribution of individual pneumococcal proteins. There was no difference in
the median survival times of cohorts (S5A Fig) (p>0.05). In addition, the mutants had grown
as well as the wild type strain in the blood at 24 and 48 h post-infection (S5B Fig), showing that
the observed reduction in virulence and colonisation in D39ΔgalK, D39ΔlacD and D39ΔlacDΔ-
galK was specific to the respiratory tract.
Overall, the results showed that Gal catabolic mutants, particularly D39ΔlacDΔgalK, were
attenuated in the ability to colonise the nasopharynx and have reduced virulence in a respirato-
ry infection mouse model.
Discussion and Conclusions
The study of S. pneumoniae has been heavily focused on factors that directly impinge on host-
pathogen interactions, such as toxins, cell wall components, adhesins and capsule [3]. In con-
trast, investigation of pneumococcal physiology has only recently been addressed, in spite of it
being a fundamental aspect of pneumococcal survival in vivo. This important pathogen is a
strictly fermentative organism, which possesses one of the highest genomic abundances of
genes encoding sugar transporters [6,7,24]. Thus, we surmised that the ability to take up and
metabolize sugars is of key importance for the lifestyle of S. pneumoniae. Our view is strongly
supported by previous studies consistently identifying genes involved in sugar catabolism as es-
sential for virulence [11,57–61] as well as reports showing that sugar transporters contribute to
S. pneumoniae colonisation and disease [16,62–64]. In the nasopharynx free sugars are scarce,
but recent findings indicate that sugars derived from deglycosylation provide suitable carbon
and energy sources for nasopharyngeal growth [12,14,15]. In order to understand the role of
different host derived sugars in pneumococcal lifestyle and pathogenicity, we followed a top-
down approach to identify, establish and validate functional sugar-specific catabolic pathways
implicated in the utilization of sugars that may originate from glycan deglycosylation and eval-
uated the impact of sugar-specific pathways on the ability to colonise and cause disease in vivo.
Despite the vast diversity of host glyconjugates, their glycan portions are often composed of
the monosaccharides GalNAc, Gal, NeuNAc, GlcNAc, Fuc, Man, Glc and fructose. While the
Fig 8. Pneumococcal strains defective in galactose catabolic pathways are less able to colonise nasopharynx.Mice were infected with
approximately 1 X 105 CFU pneumococci. At predetermined times, five mice were culled, and CFUmg-1 of bacteria were determined by serial dilutions of
nasopharyngeal homogenates. Each column represents the mean of data from five mice. Error bars show the standard error of the mean. Symbols: *
p<0.05; ** p<0.01, **** p<0.0001.
doi:10.1371/journal.pone.0121042.g008
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first five sugars are widespread in both N- and O-glycans (e.g. mucins), the other three are gener-
ally restricted to N-glycans. S. pneumoniae can grow on mucin as sole carbon source [12]. This
ability is associated to a range of glycosidases that hydrolyse the mucins releasing to the medium
neuraminic acids (NeuNAc and N-glycolylneuraminic acid), Gal and GalNAc, and to a less ex-
tent also GlcNAc and Fuc [14]. From our own analysis of the genomic content and the work of
others [8,9,14,39,49,63], S. pneumoniaeD39 harbours genes to potentially catabolise the glycan
components Gal, GlcNAc, NeuNAc andMan. A bias towards utilization of the monosaccharide
Gal and GlcNAc by S. pneumoniaeD39 during growth on an O-glycan was hypothesised, since
the monosaccharides account respectively for 14% and 30% (wt/vol) of the mucin [14]. Further-
more, S. pneumoniae is equipped with the machinery to utilize those constituents including gly-
cosidases (at least two galactosidases, BgaA and BgaC, and a N-acetylglucosaminidase StrH
[14,20,65,66]), putative transporters and catabolic genes (S4 Table). This hypothesis was corrob-
orated in a transcriptome analysis comparing gene expression of cells growing on porcine gastric
mucin to Glc. Of the genes showing significant increased expression on mucin, the vast majority
was implicated in the uptake and internal metabolism of Gal (25% of genes involved in sugar me-
tabolism (Table 1)), and GlcNAc. Of note, mucin highly induced the expression of bgaA and
strH encoding a β-galactosidase and a β-N-acetylglucosaminidase, whose activities result in free
Gal and GlcNAc, respectively [18,65–68]. Growth of S. pneumoniae on mucin was shown to re-
duce by 30% the content in Gal of the glycoprotein, while the content in GlcNAc was not altered.
This was rationalized as resulting from the complex structure of mucin, in which GlcNAc resi-
dues might be masked by other sugars.
Genes associated with the transport of Man, a monosaccharide generally found in N-glycans,
were also upregulated in mucin. Like Gal and GlcNAc, Man could sustain growth of S. pneumo-
niaeD39 in a chemically defined medium (Fig 2). Whether all the transporters upregulated
show affinity for mannose remains to be investigated. Activity of α-mannosidase has been de-
scribed for S. pneumoniae and homologues of previously characterized streptococcal mannosi-
dase genes are found in the genome of D39 [69–71], but these genes were not differentially
expressed in mucin-grown cells.
Previously, it was shown that growth on mucin required the activity of neuraminidase A
(NanA) [12]. Initial removal of terminal NeuNAc seems to be essential for further breakdown
by other glycosidases and subsequent utilization of the glycan-derived sugars [14,18,72]. In our
study, neuraminidase A was not significantly induced in presence of mucin as compared to
Glc, which leads us to propose that its constitutive expression is sufficient to ensure the activity
level to remove terminal NeuNAc. Furthermore, we (and others) verified that NeuNAc cannot
sustain growth of strain D39 in chemically defined medium, most likely due to a frame shift
mutation in the N-acetylneuraminate lyase gene of the nanAB operon [8]. The mucin deriva-
tives GalNAc and Fuc also failed to support growth of S. pneumoniae. For GalNAc we could
not firmly identify genes encoding the activities converting N-acetylgalactosamine 6-phosphate
to tagatose 6-phosphate, although genes with homology to E. coli counterparts are present in
the genome (S2 Text). Genes implicated in the downstream processing of L-lactaldehyde, the
product of L-fuculose phosphate aldolase in the Fuc pathway, were not found (S2 Text) [8].
This inability to identify the full catabolic pathways for Fuc and GalNAc is in good agreement
with previous reports that S. pneumoniae is unable to grow on these sugars as sole carbon
sources [8,50–52].
Overall, our integrated approach combining genomic, transcriptomic and growth data iden-
tified Gal, GlcNAc and Man as the glycan-originating monosaccharides more likely to be used
as substrates for growth of S. pneumoniae D39 in the respiratory tract.
The predicted routes for Gal, GlcNAc and Man dissimilation in S. pneumoniae D39 (Fig 1)
were validated at the biochemical and genetic level in this study.
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Mannose
The phosphorylated intermediate Man6P accumulated to high levels in exponential cells and
the activity of Man6P isomerase (ManA) was induced by Man. AmanAmutant was unable to
grow onMan, even though mannose 6-phosphate isomerase activity was detected to a certain
extent in the loss-of-function mutant. Homologues of genes coding for ManA or other known
Man6P isomerases were not found in the genome of D39, suggesting that the residual isomerase
activity is non-specific, and insufficient to support growth onMan, as shown in Fig 6D. Of inter-
est, a strain expressingmanA in trans under the control of an inducible zinc promoter showed
better growth than the wild type D39, suggesting a bottleneck at the level of ManA. This obser-
vation is further supported by the high accumulation of Man6P during growth on Man.
N-acetylglucosamine
Both intermediates for the catabolism of GlcNAc, GlcNAc6P and GlcN6P, were present in ex-
ponentially-growing cells. Furthermore, the activity of GlcNAc6P deacetylase was induced by
GlcNAc. A nagAmutant lost the ability to grow on the amino sugar, and the growth could be re-
stored by in trans complementation. In other bacteria GlcNAc can be taken up via PTS or non-
PTS transporters [73–78]. A recent report indicated that S. pneumoniae internalizes this amino
sugar exclusively via PTS transporter(s) [8], and this has been confirmed for strain D39 (A. M.
Cavaleiro, P. Gaspar, T. Kloosterman, O. P. Kuipers and A. R. Neves, unpublished data).
Galactose
In a previous study using a different isolate of S. pneumoniae D39, we reported activity of both
the Leloir and the T6P pathways in the utilization of Gal, since intermediates of both pathways
(α-Gal1P and α-Glc1P from the Leloir and TBP from the T6P pathway) were observed during
growth on Gal [9], and this was confirmed with D39 isolate used in the present study. Specific
activities of enzymes for the Leloir (galactokinase, GalK) or T6P (tagatose 1,6-diphosphate al-
dolase, LacD) pathways were detected during growth on Gal, but not on Glc. This result for
GalK and LacD contrasts with the activities of the other enzymes tested (NagA and ManA),
which showed activity also when grown on Glc and not only on their dedicated sugars
(Table 4). These findings may be explained by the fact that both NagA and ManA are involved
in cellular processes other than the catabolism of the monosaccharides, such as providing pre-
cursors for biosynthesis. Inactivation of both galK and lacD in D39 rendered the pneumococ-
cus unable to grow on Gal. Surprisingly, inactivation of galK alone abolished growth on Gal,
whereas exponential growth of a lacDmutant was observed although only after a long lag
phase. The behavior of the lacDmutant can be partially explained in the context of carbon ca-
tabolite repression. The Leloir genes are under strong negative control by the carbon catabolite
protein A, CcpA [9], thus alleviation of the repression is required before the pathway is activat-
ed. In line with this conclusion, in D39 Glc-grown cells the activity of galactokinase was unde-
tectable. Catabolism via the Leloir pathway is normally associated with uptake of Gal via a
non-PTS permease (secondary carriers or ABC transporters). Bidossi et al. [8], implicated the
ABC transporter SPD_0088-9-90 CUT1 in the uptake of Gal. On the other hand, a Lactococcus
lactis strain exclusively harboring the Leloir pathway, inactivated for the Gal permease, translo-
cates Gal by a PTS and the resulting Gal6P enters the Leloir pathway upon dephosphorylation
by a phosphatase [79]. The same could be active in S. pneumoniae, however, exclusive transport
via the PTS is not in agreement with the observations that S. pneumoniae G54 and DP1004 de-
void of PTS activity (ptsImutants) are capable of growing on Gal [8]. Interestingly, a D39 ptsI
mutant shows good growth on Gal, but only after a lag phase of about 11 h (A. M. Cavaleiro, P.
Gaspar, T. Kloosterman, O. P. Kuipers and A. R. Neves, unpublished data). In light of these
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results, we propose that induction of an adequate transport system, presumably a non-PTS
type, and alleviation of the carbon catabolite repression exerted over the Leloir genes are strict
requirements for Gal dissimilation via the Leloir pathway in S. pneumoniae D39. Our hypothe-
sis is in agreement with the elimination of the lag phase upon subculturing of the lacD strain
on Gal containing-medium (S6 Fig).
While the residual growth on Gal in the lacDmutant can be attributed to activation of the
Leloir pathway, we do not know why growth on Gal is totally abolished in the galKmutant. A
plausible explanation relies on the unintentional elimination of Gal1P uridylyltransferase
(GalT) activity that provides essential precursors for the biosynthesis of structural polysaccha-
rides. Indeed, inactivation of galK affected the expression of galT-2, and reversion of the galK
mutant to the wild type phenotype on Gal required complementation with both galK and galT-
2. However, inability to grow on Gal could be largely attributed to the galKmutation, since ex-
pression in trans of galT-2 did not restore growth and a galT-2mutant was able to grow on Gal
(data not shown). In the latter mutant, expression of galT-1 was substantially increased, indicat-
ing that the product of the duplicated gene accounts for the lost GalT-2 activity, thus restoring
the Leloir pathway functionality. Based on our data, we therefore conclude that Gal metabolism
in S. pneumoniae requires an operational Leloir pathway, or at least an active galactokinase.
In other streptococci, efficient dissimilation of Gal has been associated with the presence of
a high affinity specific Gal transporter [80,81]. According to Bidossi et al. [8], the PTS trans-
porters implicated in the import of Gal in S. pneumoniae are the mannose-family PTS
(ManMNL), a galactitol-family PTS (SPD_0559-0-1) and probably a mannose-family PTS
(SPD_0066-7-8-9). In addition, our team showed that lacFE genes are induced by Gal, suggest-
ing a potential contribution of the lactose-PTS to the uptake of the sugar [9]. Interestingly, the
galactitol-family PTS, which has previously been implicated in Gal uptake [8,53], is a homo-
logue of the specific galactose-PTS identified in Streptococcus gordonii, Streptococcus mutans
and Streptococcus oligofermentans [80–82]. However, the affinity of this putative galactose-spe-
cific PTS for Gal is seemingly not very high, as noted by markedly decreased growth rates at
low Gal concentration and the inability to fully scavenge Gal from the culture medium (Fig 3
and Table 2). The absence of high-affinity PTSs would certainly be a bottleneck for efficient
functionality of the T6P pathway, but cannot fully explain the galK phenotype. Moreover, the
uptake of Gal via a PTS system ensures a typical PTS-mediated signal transduction pathway
for CcpA regulation and renders Gal an effective inducer of catabolite repression [9]. Of note,
our team has previously reported that CcpA repression of key metabolic genes (Leloir pathway
and fermentative pathways) is counterbalanced by a Gal-dependent activation [9]. In view of
the results with the galKmutant we propose that galactokinase activity is essential for Gal ca-
tabolism, and that its product, α-Gal1P, is likely to be the inducer of gene expression. Collec-
tively, our data provide evidence that utilization of Gal in S. pneumoniae is subject to complex
regulation and of a subtle regulatory link between the Leloir and the T6P pathways. Unravel-
ling these regulatory mechanisms certainly deserves future investigations.
Growth in non-preferential sugars is usually associated with mixed acid fermentation pro-
files [83,84]. This is indeed the case for S. pneumoniae D39 growing on Gal as sole carbon
source (Table 3; [9]). Unexpectedly, growth on the other slowly metabolizable monosaccharide,
Man, resulted in only a modest shift towards mixed acid products suggesting a different regula-
tion of the central carbon pathways in the presence of Man. The underlying mechanisms are,
however, out of the scope of this work and will be further investigated in the future.
We hypothesised that the ability to efficiently use monosaccharides originating from mucins
conferred on S. pneumoniae a metabolic advantage during colonisation and subsequent inva-
sive states. S. pneumoniae strains defective in Gal catabolic genes, and in particular the double
mutant, D39ΔlacDΔgalK, presented impaired ability to colonise the murine nasopharynx and
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had reduced virulence. Inactivation of nagA ormanA had no significant effect in test mice. Im-
portantly, direct administration of the Gal mutants into the bloodstream induced responses of
the same magnitude (similar survival times and CFU per ml of blood) as the wild type D39
strain. In the bloodstream the main sugar present is Glc [10,11], and thus the Gal-deficient
phenotype was not expected to have any impact. Furthermore, this finding adds to the impor-
tance of Gal metabolism in the airways, further supporting the view connecting Gal metabo-
lism in S. pneumoniae to its virulence in this niche.
At first glance, the inefficient Gal metabolism and the observation that Gal is a less preferred
sugar compared to Man and GlcNAc in vitro, seems to be in conflict with the role of Gal genes
in colonisation and virulence. The lack of correlation between sugar preferences in vitro and
the effect of mutations in specific sugar catabolic pathways in vivo has been reported before for
E. coli [85]. This apparent inconsistency might arise from the multifactorial milieu in host
niches. Furthermore, we showed that Gal catabolic genes represent the largest fraction of genes
induced by mucin and others had previously established that Gal is widespread and abundant
in the airway glycoconjugates (e.g. mucins). The relevance of Gal acquisition and metabolism
had been previously suggested. Indeed, loss of beta-galactosidase activity, resulted in attenuated
pneumococcal growth in the nasopharynx [14], and mutants defective in pyruvate formate
lyase, an enzyme essential for Gal fermentation, were attenuated in virulence [39]. Further-
more, using Tn-seq in S. pneumoniae TIGR4 van Opijnen et al. [86] identified lacD as relevant
for pneumococcal fitness in the nasopharynx. In addition, they also showed that both galK and
lacD played a critical role for fitness of TIGR4 during in vitro growth on Gal. In S. pneumoniae
D39, galK is essential for growth on Gal, while loss of lacD causes a long lag phase prior to ex-
ponential growth. The different results in the two studies most likely derive from using differ-
ent serotypes (D39 vs. TIGR4) or different experimental conditions for growth of S.
pneumoniae. Nevertheless, both studies highlight the relevance of Gal and its catabolism in
the airways.
In light of these results we propose that pneumococcal Gal metabolism is of key importance
during colonisation and throughout the transition from carriage to an invasive state. The loss of
fitness in the Gal mutants can be due to metabolic impairment and deficient expression of spe-
cific virulence traits induced by Gal. We have previously reported that Gal-grown cells produce
twice as much capsule as Glc-grown cells [9], and it has been reported that a thicker capsule al-
lows evasion from immune system and from initial mucociliary clearance in vivo [87]. On Gal,
the carbon balance was lower than on other sugars, but no other end-products/metabolites were
detected, thus we propose that Gal is directed to processes other than fermentation such as the
polysaccharide synthesis [9]. Whether it is the capsule or other factors such as increased carbon
availability that determines the Gal-associated virulence remains to be investigated.
In summary, we followed a multidisciplinary approach to identify the monosaccharides in
host glycoproteins that serve as carbon sources for growth of S. pneumoniae strain D39. Accu-
mulating evidence connects pathogenesis to carbohydrate metabolism, and the findings herein
presented further strengthen this view as we specifically show that mutants in Gal catabolic
genes showed attenuated ability to colonise and reduced virulence following intranasal infec-
tion in mouse models. With widespread antibiotic resistance and re-emergence of non-type
vaccine strains, it is urgent that new targets are found for the development of novel therapeutic
and preventive drugs. One such opportunity is perhaps offered by the discovery of Gal as an
“essential” nutrient for pneumococcal growth and persistence in the host. The Leloir and the
tagatose 6-phosphate pathways are present and conserved across pneumococcal serogroups
(S8 Table) supporting our suggestion that Gal catabolism could be a potential target for
novel therapeutics.
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Supporting Information
S1 Fig. Schematic representation of N-acetylglucosamine 6-phosphate synthesis. N-acetyl-
glucosamine 6-phosphate 4 was obtained through a modification of established procedures
[46,47]. Benzylation of the anomeric hydroxyl group afforded compound 2 [47], which was se-
lectively phosphorylated at the primary hydroxyl group using dibenzyldiisopropyl phosphora-
midite and pyridinium hydrochloride followed by oxidation of the resulting phosphite, with
cumene hydroperoxide, to the corresponding phosphate 3. Hydrogenolysis of 3 with H2/Pd/C
(10%) in ethanol/water afforded N-acetylglucosamine 6-phosphate 4 quantitatively. Interest-
ingly, when the hydrogenation was performed under anhydrous conditions it was not possible
to remove the benzyl protecting group at the anomeric position.
(TIF)
S2 Fig. Schematic representation of tagatose 1,6-biphosphate 11 synthesis.Modifications to
the synthesis previously published [48] were made in order to optimize the process (details in
S1 Text). 1,2:3,4-di-O-isopropylidene-α-D-tagatofuranose 6 was obtained in one step (78%)
from D-tagatopyranose [Jenkinson et al., 2011], instead of the 4 steps required when starting
from D-galacturonic acid. Phosphorylation of 6, under the same reaction conditions used for
the synthesis of 3 (S1 Fig), afforded protected tagatose 6-phosphate 7 in 94% yield. Hydroge-
nolysis of the benzyl protecting groups of the phosphate afforded phosphate 8 and partially
hydrolysed compound 9, which was probably catalysed by the acidic hydrogen phosphate
group. However, this was not a problem, since the next step was the removal of the isopropy-
lidene acetals to afford tagatose 6-phosphate 10. The enzymatic phosphorylation [88] of
the primary alcohol at C-1 of 10 afforded tagatose 1,6-bisphosphate in 66% yield, as the
salt of triethylammonium. All attempts to chemically phosphorylate the C-1 primary
alcohol failed.
(TIF)
S3 Fig. Genomic environment of target genes. (A) Schematic representation of the genomic
context of sugar pathway mutant strains generated in this study. Mutants were constructed
by allelic replacement mutagenesis. (B) Organization of genes involved in the catabolism of
galactose (A), mannose (B) and N-acetylglucosamine (C). Genes are represented by large ar-
rows. Genes known to be involved in the catabolic reactions (S4 Table) are shown in black,
while other genes in the same operons are shown in grey. Promoters (arrows) and termina-
tors (lollipops) were determined by RNA-seq [89]. Gene annotations (as from NCBI): galR,
galactose operon repressor; galK, galactokinase; galT-2, galactose 1-phosphate uridylyltrans-
ferase; lacC, tagatose 6-phosphate kinase; lacD, tagatose 1,6-diphosphate aldolase; lacT, tran-
scription antiterminator LacT; SPD_1867, hypothetical protein; nagA, N-acetylglucosamine
6-phosphate deacetylase; SPD_1865, zinc-containing alcohol dehydrogenase; SPD_0640,
pseudo;manA, mannose 6-phosphate isomerase; SPD_0642, sodium-dependent transporter;
agaS, sugar isomerase; galM, aldose 1-epimerase; SDP_1617, cell wall surface anchor family
protein; SPD_1616, hypothetical protein; SPD_1615, hypothetical protein; SPD_1614, phos-
phate transport system regulatory protein PhoU; galT-1, galactose 1-phosphate uridylyltrans-
ferase; galE-2, UDP-glucose 4-epimerase; SPD_1611, hypothetical protein; SPD_1610,
hypothetical protein; SPD_1609, ABC transporter substrate-binding protein; SPD_1608,
ABC transporter ATP-binding protein; SPD_1607, ABC transporter permease; SPD_1606,
MgtC/SapB family protein; galE-1, UDP-glucose 4-epimerase; SPD_1431, glycosyl transfer-
ase family protein; fer, ferredoxin; SPD_1429, hypothetical protein; cmk, cytidylate kinase;
pgm, phosphoglucomutase/phosphomannomutase family protein; lacA, galactose
6-phosphate isomerase subunit LacA; lacB, galactose 6-phosphate isomerase subunit LacB;
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nagB, glucosamine 6-phosphate isomerase; rpsU, 30S ribosomal protein S21. SpeR spectino-
mycin resistance marker.
(TIF)
S4 Fig. Growth profiles of the sugar specific deletion mutants and their complemented de-
rivatives in C+Y medium. (A) Growth on galactose (Gal) of D39ΔgalK complemented with
pKB01-galKgalT-2. (B) Growth on galactose (Gal) of D39ΔlacD complemented with pKB01-
lacD. (C) Growth on N-acetylglucosamine (GlcNAc) of D39ΔnagA complemented with
pKB01-nagA. (D) Growth on mannose (Man) of D39ΔmanA complemented with pKB01-
manA. Growths were made in C+Y (without sucrose and glucose) with or without 0.1 mM
ZnCl2, at 37ºC. Symbols: (dash) D39 grown in presence of zinc; (grey triangle) D39 loss-of-
function mutants grown in presence of zinc; (closed circle) complemented strains grown in
presence of zinc; (open circle) complemented strains grown without Zn; (cross) D39 grown
without Zn; (open triangle) D39ΔnagA grown without Zn.
(TIF)
S5 Fig. Analysis of pneumococcal strains in bacteremia model.Mice were infected intrave-
nously with 100 μl PBS containing approximately 5 X105 CFU through dorsal tail vein. (A) The
animals were monitored over 168 h. Symbols show the times when individual mice became se-
verely lethargic, the point when the animals were culled. The horizontal bars mark the median
times to the severely lethargic state. (B) Growth of bacteria in the blood. Each point is the mean
of data from five mice. Error bars show the standard error of the mean.
(TIF)
S6 Fig. Subculturing of S. pneumoniaeD39ΔlacD in chemically defined medium (CDM)
supplemented with galactose (Gal). (A) Pre-culture of S. pneumoniae D39ΔlacD in CDM-Gal
(55 mM). 1 ml glycerol stock inoculated in 80 ml CDM-Gal (see Materials and Methods).
(B) Subculturing of S. pneumoniae D39ΔlacD. Inoculation of fresh CDM-Gal (30 mM), to an
initial optical density at 600 nm (OD600) of ~ 0.05, with a pre-culture grown in the same sugar
(Gal) until late-exponential phase of growth. Growth was performed at 37ºC, under semi-an-
aerobic conditions, without pH control (initial pH 6.5).
(TIF)
S1 Table. Bacterial strains and plasmids used in this study.
(DOCX)
S2 Table. Pairwise comparisons, across combinations of different sugars and initial sub-
strate concentrations, to test the null hypothesis of equal values for the μmax and ODmax.
(DOCX)
S3 Table. Oligonucleotide primers used in this study (from 5’ to 3’).
(DOCX)
S4 Table. Genes proposed to be involved in the uptake and dedicated catabolism of galac-
tose (Gal), mannose (Man), N-acetylneuraminic acid (NeuNAc), N-acetylglucosamine
(GlcNAc), fucose (Fuc), and glucose (Glc) in S. pneumoniae D39.
(DOCX)
S5 Table. Expression levels of genes upregulated in S. pneumoniaeD39 cells grown in
mucin as compared to glucose-grown cells, according to the established criterion (see
Materials and Methods).
(DOCX)
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S6 Table. Expression ratio as determined by qRT-PCR of genes selected from the microar-
ray experiment comparing mRNA levels in mucin-grown to glucose-grown S. pneumoniae
D39 cells.
(DOCX)
S7 Table. Expression ratio of genes involved in galactose catabolism in exponentially grow-
ing S. pneumoniaeD39 cells disrupted in galK or galT-2 genes.
(DOCX)
S8 Table. Galactose metabolic genes in different S. pneumoniae strains.
(XLSX)
S1 Text. Modifications to the previously published synthesis of tagatose 1,6-biphosphate.
(DOCX)
S2 Text. Genomic potential for the utilization of host monosaccharides.
(DOCX)
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